SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Isotechnika -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (54)5/22/2003 11:47:33 PM
From: teevee  Respond to of 285
 
Biomaven,

Thanks for the URL on FDA guidance. I have bookmarked it.

cheers,
teevee



To: Biomaven who wrote (54)6/1/2003 11:45:07 AM
From: teevee  Respond to of 285
 
Biomaven,
Of course fast track status is not a magic bullet - some drugs that qualify for fast track never get approval as a drug or even make it to an NDA. In general companies (especially smaller ones) make too big a deal of fast track status.

Did you ever hit the nail on the head with that statement. Here is a link to an article that gives some insight into the performance of companies who obtain "fast track" status.

signalsmag.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News